Aigen Investment Management »

Intra Cellular Therapies shares owned by Aigen Investment Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Aigen Investment Management from 13F filings

Historical chart of Aigen Investment Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Aigen Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Aigen Investment Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.7M 20k 83.52
2024-09-30 $1.1M 15k 73.17
2024-06-30 $533k 7.8k 68.49
2023-06-30 $900k 14k 63.32
2023-03-31 $455k 8.4k 54.15
2020-09-30 $1.7M 65k 25.66
2019-12-31 $41k 1.2k 34.20

More positions owned by Aigen Investment Management

Meta Platforms Cl A (META)
Honeywell International (HON)
Boston Scientific Corporation (BSX)
Nrg Energy Com New (NRG)
Microsoft Corporation (MSFT)
Charles Schwab Corporation (SCHW)
Keurig Dr Pepper (KDP)
Citigroup Com New (C)
O'reilly Automotive (ORLY)
Norfolk Southern (NSC)
Chubb (CB)
NVIDIA Corporation (NVDA)
Fiserv (FI)
Hf Sinclair Corp (DINO)
Metropcs Communications (TMUS)

View all positions for Aigen Investment Management

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies